Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii

被引:203
作者
Poirel, L [1 ]
Nordmann, P [1 ]
机构
[1] Univ Paris 11, Serv Bacteriol Virol, Hop Paris, Fac Med Paris Sud,Hop Bicetre, F-94275 Le Kremlin Bicetre, France
关键词
D O I
10.1128/AAC.50.4.1442-1448.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Genetic structures surrounding the carbapenem-hydrolyzing oxacillinase gene bla(OXA-58) were characterized in a series of OXA-58-positive Acinetobacter baumannii strains isolated from different countries. We showed that in most of the cases, acquisitions of the bla(OXA)-58-containing overall structure, including insertion sequence elements, may be likely the results of recombination events. In type strain A. baumannii MAD, the genetic structure surrounding the bla(OXA-58) gene was bracketed by two 27-bp repeated sequences. The isolation of a clonally related OXA-58-negative A. baumannii isolate that possessed the same plasmid backbone as A. baumannii MAD but lacked this genetic structure indicated that the mechanism of acquisition could be reversible. Parts of the structure identified in A. baumannii MAD were conserved in other bla(OXA-58)-positive isolates from various European countries. Primer extension experiments showed that blaOXA-58 expression was related to promoter sequences brought by different insertion sequence elements, such as an ISAba3-like element, ISAba1, ISAba2, and IS18. This work identified novel structures at the origin of acquisition and expression of a carbapenem-hydrolyzing P-lactamase identified in non-clonally related A. baumannii isolates.
引用
收藏
页码:1442 / 1448
页数:7
相关论文
共 29 条
  • [11] A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58
    Héritier, C
    Dubouix, A
    Poirel, L
    Marty, N
    Nordmann, P
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) : 115 - 118
  • [12] Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii
    Héritier, C
    Poirel, L
    Fournier, PE
    Claverie, JM
    Raoult, D
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (10) : 4174 - 4179
  • [13] Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii
    Héritier, C
    Poirel, L
    Aubert, D
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 268 - 273
  • [14] INSERTION OF IS2 CREATES A NOVEL AMPC PROMOTER IN ESCHERICHIA-COLI
    JAURIN, B
    NORMARK, S
    [J]. CELL, 1983, 32 (03) : 809 - 816
  • [15] FACTORS AFFECTING THE ISOLATION OF CCC DNA FROM STREPTOMYCES-LIVIDANS AND ESCHERICHIA-COLI
    KIESER, T
    [J]. PLASMID, 1984, 12 (01) : 19 - 36
  • [16] Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe
    Marqué, S
    Poirel, L
    Hériteir, C
    Brisse, S
    Blasco, MD
    Filip, R
    Coman, G
    Naas, T
    Nordmann, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4885 - 4888
  • [17] Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a Tertiary Care Hospital of Papeete, French Polynesia
    Naas, T
    Levy, M
    Hirschauer, C
    Marchandin, H
    Nordmann, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4826 - 4829
  • [18] Emerging carbapenemases in Gram-negative aerobes
    Nordmann, P
    Poirel, L
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (06) : 321 - 331
  • [19] Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene
    Poirel, L
    Naas, T
    Guibert, M
    Chaibi, EB
    Labia, R
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (03) : 573 - 581
  • [20] Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae
    Poirel, L
    Héritier, C
    Tolün, V
    Nordmann, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 15 - 22